Press release
August 5, 2026
Stoke Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
Stoke Therapeutics, Inc. (STOK)
BEDFORD, Mass. --(BUSINESS WIRE)--Aug. 5, 2026-- Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a